IP Library Patent Application 17611929
Patent Application
App. No. 17/611,929

RADIOTHERAPEUTIC MICROSPHERES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/611,929
Abstract

Certain embodiments are directed to compositions comprising and method for producing alginate microspheres that contain liposomes encapsulating a variety of useful substances. Substances of note that can be encapsulated in liposomes and loaded alginate microspheres include radiotherapeutics (e.g., rhenium-188), radiolabels (e.g., technetium-99m), chemotherapeutics (doxorubicin), magnetic particles (e.g., 10 m iron nanoparticles), and radio-opaque material (e.g., iodine contrast).

Claims (17)

1 . A method for producing liposome containing alginate microspheres comprising: Atomizing, using an atomizer, a liposome/alginate solution into a curing solution comprising an alginate cross-linker, and isolating liposome containing alginate microsphere having an average diameter of 20 to 80 μm.

2 . The method of claim 1 , wherein the atomizer is an ultrasonic nozzle.

3 . The method of claim 2 , wherein the ultrasonic nozzle is a 1 Hz to 100 kHz nozzle.

4 . The method of claim 2 , wherein the ultrasonic nozzle is a 25 kHz nozzle.

5 . The method of claim 1 , wherein the atomizer is positioned 1 to 10 cm from the curing solution.

6 . The method of claim 1 , wherein the curing solution comprises a cation.

7 . The method of claim 6 , wherein the cation is selected from calcium, strontium, barium, iron, silver, aluminum, magnesium, manganese, copper, and zinc.

8 . The method of claim 1 , wherein the curing solution comprises CaCl 2 .

9 . The method of claim 1 , wherein the liposome/alginate solution comprises a liposome to alginate ratio of 1:1.

10 . The method of claim 1 , wherein the liposomes comprise a therapeutic agent or an imaging agent.

11 . The method of claim 10 , wherein the therapeutic agent is a thermotherapeutic, a chemotherapeutic, or a radiotherapeutic agent.

12 . A liposome containing alginate microsphere comprising:

(a) an alginate microsphere having an average diameter of 20 to 80 μm; and

(b) liposomes dispersed in the alginate microsphere, the liposome containing a therapeutic and/or imaging agent.

13 . A method for performing embolization therapy on a subject having a tumor comprising injecting the liposome containing alginate microsphere of claim 12 into the tumor vasculature.

14 . A thermotherapeutic alginate microsphere comprising a thermotherapeutic agent encapsulated in an alginate microsphere.

15 . The microsphere of claim 14 , wherein the thermotherpeutic agent is encapsulated in a liposome that is contained in an alginate microsphere.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 11, 2024
From: OXFORD FINANCE LLC
To: PLUS THERAPEUTICS, INC.
Reel/Frame 068877/0700 →
FIRST AMENDMENT TO THE INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 23, 2022
From: PLUS THERAPEUTICS, INC. (F/K/A CYTORI THERAPEUTICS, INC.)
To: OXFORD FINANCE LLC
Reel/Frame 061302/0335 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2021
From: PHILLIPS, WILLIAM T; BITAR, RYAN
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 058354/0037 →